You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Integrated molecular diagnostic system for the point-of-care
SBC: BIOHELIX CORPORATION Topic: NIAIDDESCRIPTION (provided by applicant): This STTR-AT-NIAID seeks to develop an integrated nucleic acid system based on research done by Catherine Klapperich's laboratory at Boston University. The BU lab-on-a-chip includes a micro solid phase extraction (lt SPE) column, flap valves and hydrophobic vents to gate fluid movements through micro channels, and multiple reaction chambers for experimenta ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Isolation of functional IgGs in the cytoplasm of a novel E. coli expression host
SBC: NEW ENGLAND BIOLABS, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Monoclonal antibodies (mAbs) hold great promise in human health with applications ranging from therapeutic agents that target cancer cells, to diagnostic biomarkers that can detect trace levels of a given antigen. Thispromise is best reflected in global sales of antibodies which reached nearly 31 billion in 2007 and future sales predicted to reach 56 billion ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
A NOVEL BIS-INDOLE COMPOUND AGAINST CATHETER COLONIZATION
SBC: MICROBIOTIX, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Infections associated with medical devices can be serious and even fatal. Catheter colonization and production of a biofilm on the surface of a catheter shortly after implantation are normally the prelude for infections. A number of antimicrobial-treated catheters have been developed to combat these infections, however, many of them have limited clinical effica ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Developing small molecule therapeutics for lupus
SBC: Biomedical Research Models, Inc. Topic: NIAMSDESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) affects ~ 2 million Americans with devastating impact on multiple organs, especially the skin, joints, kidney, and brain. Therapeutic strategies for lupus are largely palliative orimmunosuppressive with serious toxicities. No new drugs for SLE have been approved in decades. Thus, novel therapeutic approaches to lupus - par ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors
SBC: ARISAPH PHARMACEUTICALS, INC. Topic: NCIDESCRIPTION (provided by applicant): Cancer is America's second leading cause of death. Many approved cancer drugs, such as bortezomib (Velcade), are cytotoxic agents that kill normal cells as well as tumor cells. Therapeutic benefit depends on tumor cellsbeing more sensitive than normal cells, thereby allowing clinical responses to be achieved at relatively safe drug doses; however, damage t ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
High-throughput portable software for fragment-based drug design
SBC: ACPHARIS Topic: NIGMSDESCRIPTION (provided by applicant): Fragment-based drug design (FBDD) is a combinatorial approach in which individual fragments binding to regions of the target site are selected from a fragment library, and then combined to form potential lead compounds.Interest in this approach has significantly increased during the last few years, with many companies using FBDD methods based on X-ray crystallo ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Emergency Operations Plans for Individuals with Disabilities
SBC: PRAXIS, INC. Topic: NICHDDESCRIPTION (provided by applicant): The proposed project is designed to fill an important yet unmet need by developing an online training program that has the potential for reaching all emergency managers, responders and students in the field of emergencypreparedness with a specific focus on individuals with disabilities. Pursuing this objective, the applicant organization, Praxis, Inc., and the ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Noninvasive neonatal glucose monitor
SBC: FLUOROMETRIX CORPORATION Topic: NICHDDESCRIPTION (provided by applicant): Abnormally low (hypoglycemia) and abnormally high (hypoglycemia) glucose in neonates can lead to devastating consequences. Thus, constant, accurate and safe glucose monitoring is imperative in neonatal care. However, point-of-care (POC) devices for glucose testing currently used for neonates are originally designed for adults. Thus, they do not address issues s ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
in vivo Studies of Clinical Stage Globin Modulators
SBC: Phoenicia Biosciences, Inc. Topic: NHLBIDESCRIPTION (provided by applicant): Inherited disorders which decrease production or alter structure of the 2-chain of hemoglobin A (2-thalassemias or sickle cell disease) are among the most common monogenic diseases in the world, afflicting millions worldwide, and are designated by WHO as a global health burden. Fetal hemoglobin (HbF: 12, 32) is another type of hemoglobin which is present in all ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Compact Debridement and Treatment Delivery Device for Dermal Wound Care
SBC: PHARMACUTE, LLC Topic: NIMHDDESCRIPTION (provided by applicant): While decubitus ulcers, or bedsores, have affected millions of geriatric and other bedridden patients for centuries, little progress has been made in creating a radically successful dermal wound treatment methodology. Asolution which prevents the potential tissue damage of adhesion and replaces the ineffectiveness of wet-to-damp gauze dressings, the most common ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health